Reversal of neuromuscular block with sugammadex compared with neostigmine and postoperative pulmonary complications in obese patients: meta-analysis and trial sequential analysis

Michele Carron; Enrico Tamburini; Giovanna Ieppariello; Federico Linassi

doi:10.1016/j.bja.2023.03.003

Reversal of neuromuscular block with sugammadex compared with neostigmine and postoperative pulmonary complications in obese patients: meta-analysis and trial sequential analysis

Br J Anaesth. 2023 Jun;130(6):e461-e463. doi: 10.1016/j.bja.2023.03.003. Epub 2023 Apr 5.

Authors

Michele Carron¹, Enrico Tamburini², Giovanna Ieppariello³, Federico Linassi⁴

Affiliations

¹ Department of Medicine - DIMED, Section of Anaesthesiology and Intensive Care, University of Padova, Padova, Italy. Electronic address: michele.carron@unipd.it.
² Department of Medicine - DIMED, Section of Anaesthesiology and Intensive Care, University of Padova, Padova, Italy.
³ Institute of Anaesthesia and Intensive Care - Azienda Ospedale Università Padova, Padova, Italy.
⁴ Department of Anaesthesia and Intensive Care, Ca' Foncello Treviso Regional Hospital, Treviso, Italy.

PMID: 37028987
DOI: 10.1016/j.bja.2023.03.003

No abstract available

Keywords: anaesthesia; neuromuscular block; neuromuscular blocking agent; obesity; postoperative complications; respiratory insufficiency; sugammadex; surgery.

Publication types

Meta-Analysis
Letter

MeSH terms

Cholinesterase Inhibitors
Humans
Neostigmine* / therapeutic use
Neuromuscular Blockade* / adverse effects
Postoperative Complications
Sugammadex

Substances

Neostigmine
Sugammadex
Cholinesterase Inhibitors